Pages that link to "Q50629470"

The following pages link to MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein (Q50629470):

Displaying 28 items.

• Clinical significance of microRNAs in chronic and acute human leukemia (Q26749533) (← links)
• miRNAs as Biomarkers in Chronic Myelogenous Leukemia (Q28087081) (← links)
• miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells (Q36070278) (← links)
• Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma (Q36509109) (← links)
• High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions (Q38671635) (← links)
• The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies (Q38747300) (← links)
• Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay. (Q38866390) (← links)
• miRNAs in chronic myeloid leukemia: small molecules, essential function (Q38979577) (← links)
• The miR-30 family: Versatile players in breast cancer (Q39202832) (← links)
• Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML. (Q41082813) (← links)
• Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy (Q41457379) (← links)
• MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma (Q42315789) (← links)
• miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL. (Q42370786) (← links)
• MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma. (Q42931487) (← links)
• Developments in Hematopoietic Stem Cell Expansion and Gene Editing Technologies (Q47438268) (← links)
• MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer. (Q47825471) (← links)
• MicroRNA-9 functions as a tumor suppressor and enhances radio-sensitivity in radio-resistant A549 cells by targeting neuropilin 1. (Q49800445) (← links)
• Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment (Q50123249) (← links)
• MicroRNA Microarray Profiling during Megakaryocyte Differentiation of Cord Blood CD133 Hematopoietic Stem Cells. (Q55352766) (← links)
• Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D. (Q55442464) (← links)
• T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system. (Q55517432) (← links)
• Melatonin and Infection Altered miR-294, miR-30e, and miR-302d Impacting on , , and 2 Expression (Q64069831) (← links)
• Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients (Q64096951) (← links)
• The role and mechanisms of action of microRNAs in cancer drug resistance (Q64237748) (← links)
• MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. (Q64963067) (← links)
• Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance (Q90274839) (← links)
• Repression of MicroRNA-30e by Hepatitis C Virus Enhances Fatty Acid Synthesis (Q92112830) (← links)
• Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications (Q92287236) (← links)